Search results
FDA vaccine advisers vote unanimously in favor of updated Covid-19 shot for fall
CNN.com· 10 hours agoThe committee voted on the question, “For the 2024-2025 Formula of COVID-19 vaccines in the U.S.,...
FDA advisers urge targeting JN.1 strain in recipe for fall’s COVID vaccines
The Nashua Telegraph· 1 hour agoCOVID-19 vaccines get updated each fall to match newer strains of the virus and government advisers...
Adults 60+ Will Have 3 RSV Vaccines to Choose From This Year
Verywell Health via Yahoo News· 11 hours agoThe Food and Drug Administration (FDA) has approved mRESVIA, a new vaccine made by Moderna, to help...
FDA Panel to Consider Updating COVID-19 Jabs for New Virus Strains
Zacks via Yahoo Finance· 2 days agoAn FDA panel meeting is scheduled on Jun 5 to consider if COVID-19 vaccines should be updated to...
FDA panel supports switch to JN.1 for fall COVID vaccines
Center for Infectious Disease Research and Policy· 11 hours agoVaccine advisers to the Food and Drug Administration (FDA) today recommended switching the...
FDA approves Moderna’s RSV vaccine mRESVIA
Pharmaceutical Technology via Yahoo Finance· 3 days agoModerna has secured approval from the US Food and Drug Administration (FDA) for its mRNA-based respiratory syncytial virus (RSV) vaccine mRESVIA...
FDA to vote Wednesday on COVID-19 shots to target emerging variants in US for 2024-25
Detroit News· 1 day agoA U.S. Food and Drug Administration advisory committee will meet Wednesday to recommend a COVID-19...
New COVID-19 vaccine for fall should target JN.1 lineage, not variant, FDA panel
USA TODAY via Yahoo News· 13 hours agoOfficials noted that COVID-19 is rapidly evolving. The goal of the group was to capture the virus’...
Response To FDA Black Box Warning
BioresearchOnline· 3 days agoThe FDA has launched an investigation into the risk of T-cell malignancies following CAR-T cell immunotherapies, which involve genetically engineering T...
Moderna Scores FDA Approval For Its Second Product - Respiratory Syncytial Virus Vaccine
Benzinga via Yahoo Finance· 6 days agoOn Friday, the FDA approved Moderna Inc’s (NASDAQ:MRNA) mRESVIA (mRNA-1345), an mRNA respiratory...
